ETILX (ETILX) Stock Price & Analysis
ETILX (ETILX) rose 0.61% to USD 63.84 as of June 10, 2026 at 18:27 UTC, according to Nexqual real-time market data.
ETILX last closed at USD 63.45; the session ranged USD 63.84–63.84 on volume of 0 shares. Market capitalization is —, with a 52-week range of USD 50.93–65.15 (NAS). Source: Nexqual, June 10, 2026 at 18:27 UTC.
Key Statistics (as of June 10, 2026 at 18:27 UTC)
| Price | USD 63.84 |
|---|---|
| Change | ▲ 0.61% (up) |
| Previous Close | USD 63.45 |
| Open | USD 63.84 |
| Day Range | USD 63.84 – 63.84 |
| 52-Week Range | USD 50.93 – 65.15 |
| Volume | 0 shares |
| Market Cap | — |
| Exchange | NAS |
Technical Analysis (ETILX)
Nexqual's technical model rates ETILX "STRONG BUY" based on 5 bullish and 0 bearish signals across 124 daily candles, as of June 10, 2026 at 18:27 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 60.07 (neutral) |
| vs SMA50 | Above (USD 59.54) |
| MACD | 1.27 (positive) |
Financial Health Score (ETILX)
Nexqual rates ETILX's overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 18:27 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Mixed — No data |
| Balance Sheet | Mixed — No data |
| Cash Flow | Mixed — No data |
| Efficiency | Mixed — No data |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ETIHX | Eventide Healthcare & Life Scie | USD 48.93 | ▲ 2.15% |
| ETIDX | Eventide Dividend Opportunities | USD 22.27 | ▲ 0.81% |
| ETGLX | Eventide Gilead Fund | USD 61.17 | ▲ 0.63% |
| ETIMX | Eventide Multi-Asset Income Fun | USD 15.42 | ▲ 0.46% |
| ETIEX | Eventide Exponential Technologi | USD 16.98 | ▼ 0.93% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 18:27 UTC. This page is informational and not investment advice.